Efficacy and Safety Study of Aprepitant Injection for Prevention of Post-operative Nausea and Vomiting

Clinical trial NCT06932107 · COMPLETED

Trial details

NCT number: NCT06932107
Sponsor: Qilu Pharmaceutical (Hainan) Co., Ltd.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Postoperative Nausea and Vomiting

Start date: 2024-02-02
Primary completion: 2024-05-28
Enrollment: 518

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.